Zepbound (tirzepatide)

AAD: Ixekizumab + Tirzepatide Boosts Psoriatic Arthritis Outcomes More Than Ixekizumab Monotherapy

Physician’s Briefing

AAD: Ixekizumab + Tirzepatide Boosts Psoriatic Arthritis Outcomes More Than Ixekizumab Monotherapy

06 Apr 2026

2 min read

T2D Patient-Reported Outcomes Improved After Switching From Dulaglutide to Tirzepatide

Physician’s Briefing

T2D Patient-Reported Outcomes Improved After Switching From Dulaglutide to Tirzepatide

01 Apr 2026

2 min read

Tirzepatide Use Linked to Lower Risk for Diabetic Retinopathy

Physician’s Briefing

Tirzepatide Use Linked to Lower Risk for Diabetic Retinopathy

20 Feb 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com